These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 30497486)
1. Fufang-Zhenzhu-Tiaozhi Capsule reduces restenosis via the downregulation of NF-kappaB and inflammatory factors in rabbits. Zhang R; Li T; Guo J; Zhao Y; Liu Y; Yao Y; Zeng Z Lipids Health Dis; 2018 Nov; 17(1):272. PubMed ID: 30497486 [TBL] [Abstract][Full Text] [Related]
2. Fufang-Zhenzhu-Tiaozhi capsule ameliorates rabbit's iliac artery restenosis by regulating adiponectin signaling pathway. Li T; Zhang R; Liu Y; Yao Y; Guo J; Zeng Z Biomed Pharmacother; 2020 Aug; 128():110311. PubMed ID: 32502838 [TBL] [Abstract][Full Text] [Related]
3. The traditional Chinese medicine formula Fufang-Zhenzhu-Tiaozhi protects myocardia from injury in diabetic minipigs with coronary heart disease. Song L; Zhang D; Guo C; Gu Z; Wang L; Yao YS; Wang H; Zeng Z; Wang W; Yang Y; Bei W; Rong X; Guo J Biomed Pharmacother; 2021 May; 137():111343. PubMed ID: 33761594 [TBL] [Abstract][Full Text] [Related]
4. The Chinese medicine Fufang Zhenzhu Tiaozhi capsule protects against renal injury and inflammation in mice with diabetic kidney disease. Yang YQ; Tan HB; Zhang XY; Zhang YZ; Lin QY; Huang MY; Lin ZY; Mo JZ; Zhang Y; Lan T; Bei WJ; Guo J J Ethnopharmacol; 2022 Jun; 292():115165. PubMed ID: 35247475 [TBL] [Abstract][Full Text] [Related]
5. Chinese medicine Fufang Zhenzhu Tiaozhi capsule ameliorates coronary atherosclerosis in diabetes mellitus-related coronary heart disease minipigs. Wang L; Zhang D; Zhan W; Zeng Z; Yin J; Wang K; Wang H; Song L; Gu Z; Guo C; Zhong Q; Wang W; Rong X; Bei W; Guo J Biomed Pharmacother; 2022 Dec; 156():113831. PubMed ID: 36228370 [TBL] [Abstract][Full Text] [Related]
6. Vaspin inhibited proinflammatory cytokine induced activation of nuclear factor-kappa B and its downstream molecules in human endothelial EA.hy926 cells. Liu S; Dong Y; Wang T; Zhao S; Yang K; Chen X; Zheng C Diabetes Res Clin Pract; 2014 Mar; 103(3):482-8. PubMed ID: 24418398 [TBL] [Abstract][Full Text] [Related]
7. Amelioration by catalpol of atherosclerotic lesions in hypercholesterolemic rabbits. Liu JY; Zhang DJ Planta Med; 2015 Feb; 81(3):175-84. PubMed ID: 25671384 [TBL] [Abstract][Full Text] [Related]
8. The Chinese medicine Fufang Zhenzhu Tiaozhi capsule protects against atherosclerosis by suppressing EndMT via modulating Akt1/β-catenin signaling pathway. Diao H; Cheng J; Huang X; Huang B; Shao X; Zhao J; Lan D; Zhu Q; Yan M; Zhang Y; Rong X; Guo J J Ethnopharmacol; 2022 Jul; 293():115261. PubMed ID: 35447198 [TBL] [Abstract][Full Text] [Related]
9. Human apolipoprotein A-I exerts a prophylactic effect on high-fat diet-induced atherosclerosis via inflammation inhibition in a rabbit model. Li J; Wang W; Han L; Feng M; Lu H; Yang L; Hu X; Shi S; Jiang S; Wang Q; Ye L Acta Biochim Biophys Sin (Shanghai); 2017 Feb; 49(2):149-158. PubMed ID: 28069582 [TBL] [Abstract][Full Text] [Related]
10. Fufang Zhenzhu Tiaozhi (FTZ) suppression of macrophage pyroptosis: Key to stabilizing rupture-prone plaques. Shao X; Zeng W; Wang Q; Liu S; Guo Q; Luo D; Luo Q; Wang D; Wang L; Zhang Y; Diao H; Piao S; Yan M; Guo J J Ethnopharmacol; 2024 Apr; 324():117705. PubMed ID: 38219878 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of Shoushen granule on adenosine triphosphate binding cassette transporter A1, proprotein convertase subtilisin/kexin type 9 and toll-like receptor 4/nuclear factor kappa-B signaling pathway in ApoE-knockout mice. Li S; Cao H; Shen D; Chen C; Xing S; Dou F; Jia Q J Tradit Chin Med; 2019 Aug; 39(4):524-534. PubMed ID: 32186100 [TBL] [Abstract][Full Text] [Related]
12. The anti-inflammatory effect of kaempferol on early atherosclerosis in high cholesterol fed rabbits. Kong L; Luo C; Li X; Zhou Y; He H Lipids Health Dis; 2013 Jul; 12():115. PubMed ID: 23895132 [TBL] [Abstract][Full Text] [Related]
13. Guanxinping ameliorates atherosclerosis via MAPK/NF-κB signaling pathway in ApoE Zhang S; Zhang S; Liang X; Huang Y; Tang L; Liu F; Xu X; Ye F; Liu J; Liu J; Yan S; Han X Perfusion; 2023 Apr; 38(3):557-566. PubMed ID: 35102779 [TBL] [Abstract][Full Text] [Related]
14. Inflammation inhibition and gut microbiota regulation by TSG to combat atherosclerosis in ApoE Li F; Zhang T; He Y; Gu W; Yang X; Zhao R; Yu J J Ethnopharmacol; 2020 Jan; 247():112232. PubMed ID: 31606534 [TBL] [Abstract][Full Text] [Related]
15. [Resveratrol reduces inflammatory cytokines via inhibiting nuclear factor-κB and mitogen-activated protein kinase signal pathway in a rabbit atherosclerosis model]. Song R; Li WQ; Dou JL; Li L; Hu YJ; Guo JZ; Lu D; Zhang G; Sun L Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Oct; 41(10):866-9. PubMed ID: 24377894 [TBL] [Abstract][Full Text] [Related]
16. [Effect of bushen kangshuai tablet on NF-kappaB signal pathway and inflammation factors in rabbits with experimental atherosclerosis]. Zhang JP; Xu YZ; Li M Zhongguo Zhong Xi Yi Jie He Za Zhi; 2009 Sep; 29(9):816-20. PubMed ID: 19960980 [TBL] [Abstract][Full Text] [Related]
17. [The effect of fufang zhenzhu tiaozhi capsule on lipid metabolism in atherosclerotic rabbits]. Tang CP; Jiang T; Guo J; Wei YP; Yang CY; Chen FC Zhong Yao Cai; 2010 Aug; 33(8):1285-9. PubMed ID: 21213542 [TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of co-administration of atorvastatin and endothelin-1 receptor antagonist on the progression of atherosclerosis in rabbit. Sun Y; Liu J; Yang B; Sai X; Li T; Wang D; Zhou R APMIS; 2014 Jun; 122(6):556-64. PubMed ID: 24164644 [TBL] [Abstract][Full Text] [Related]
19. Atorvastatin decreases C-reactive protein-induced inflammatory response in pulmonary artery smooth muscle cells by inhibiting nuclear factor-kappaB pathway. Li J; Li JJ; He JG; Nan JL; Guo YL; Xiong CM Cardiovasc Ther; 2010; 28(1):8-14. PubMed ID: 20074254 [TBL] [Abstract][Full Text] [Related]
20. [Danlou Tablet Fought against Inflammatory Reaction in Atherosclerosis Rats with Intermingled Phlegm and Blood Stasis Syndrome and Its Mechanism Study]. Chen J; Cai HW; Miao J; Xu XM; Mao W Zhongguo Zhong Xi Yi Jie He Za Zhi; 2016 Jun; 36(6):703-8. PubMed ID: 27491230 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]